ACAD peer analysis
Acadia Pharmaceuticals (ACAD) against its competitors: price, today's move, 1-year return and market value side by side.
ACAD and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ANRO Alto Neuroscience | $22.16 | -1.95% | 54.75% | – |
| AVXL Anavex Life Sciences | $1.19 | -8.46% | -85.18% | $110.31M |
| AXSM Axsome Therapeutics | $136.07 | -5.79% | 2.19% | $7.57B |
| CTNM Contineum Therapeutics | $9.58 | 2.02% | -9.11% | – |
| LBRX LB Pharmaceuticals | $39.03 | -1.68% | 139.77% | – |
| MPLT MapLight Therapeutics | $7.58 | -1.81% | -58.74% | – |
| NMRA Neumora Therapeutics | $0.37 | -5.43% | -87.47% | – |
| PRAX Praxis Precision Medicines | $273.58 | -4.32% | 36.11% | – |
| RAPP Rapport Therapeutics | $25.10 | 0.20% | -6.62% | – |
| VNDA Vanda Pharmaceuticals | $3.79 | -6.42% | -12.27% | $229.18M |
| ACAD Acadia Pharmaceuticals | $20.47 | -0.58% | -9.98% | $3.55B |
- ACAD's peers: ANRO (Alto Neuroscience), AVXL (Anavex Life Sciences), AXSM (Axsome Therapeutics), CTNM (Contineum Therapeutics), LBRX (LB Pharmaceuticals), MPLT (MapLight Therapeutics), NMRA (Neumora Therapeutics), PRAX (Praxis Precision Medicines).
Updated 2026-11-03 00:02 UTC